April 15 (Reuters) - Vicplas International Ltd VICP.SI :
* MEDICAL DEVICES SEGMENT OPERATIONS HAVE NORMALISED,
CAUTIOUSLY
OPTIMISTIC ABOUT PERFORMANCE FOR H2
* ADDITIONAL CIRCUIT BREAKER MEASURES INTRODUCED BY
SINGAPORE
GOVERNMENT NOT EXPECTED TO IMPACT MDS SIGNIFICANTLY
* SINGAPORE MANUFACTURING FACILITY HAS BEEN GRANTED
PERMISSION TO
CONTINUE OPERATIONS DURING CIRCUIT BREAKER PERIOD
* GROUP'S PIPES AND PIPE FITTINGS SEGMENT HAS BEEN AFFECTED
BY
RECENT RESTRICTIONS IN MALAYSIA AND SINGAPORE DUE TO COVID-19
* SINGAPORE AND MALAYSIA MANUFACTURING FACILITIES ARE
RUNNING AT
REDUCED SCALE WITH SUBSTANTIALLY FEWER EMPLOYEES
* CUSTOMERS' DEMAND FOR PIPES AND PIPE FITTINGS IN SINGAPORE
EXPECTED TO DECREASE SIGNIFICANTLY DURING CIRCUIT BREAKER PERIOD
* DEMAND FOR PIPES AND PIPE FITTINGS IN SINGAPORE EXPECTED
TO
DECREASE SIGNIFICANTLY DURING THIS CIRCUIT BREAKER PERIOD
* AT THIS STAGE, PIPES AND PIPE FITTINGS SEGMENT IS UNABLE
TO
DETERMINE EXTENT OF FINANCIAL IMPACT OF COVID-19
Source text for Eikon: ID:nSN7hdNSx
Further company coverage: VICP.SI
((Reuters.Briefs@thomsonreuters.com;))